Journal Articles
2020

COVID-19: Magnifying the Effect of Health Disparities
E. J. Kim
Zucker School of Medicine at Hofstra/Northwell, ekim7@northwell.edu

L. Marrast
Zucker School of Medicine at Hofstra/Northwell, lmarrast@northwell.edu

J. Conigliaro
Zucker School of Medicine at Hofstra/Northwell, jconigliaro@northwell.edu

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Internal Medicine Commons

Recommended Citation
Kim EJ, Marrast L, Conigliaro J. COVID-19: Magnifying the Effect of Health Disparities. . 2020 Jan 01;
35(8):Article 6250 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/6250. Free
full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu.

COVID-19: Magnifying the Effect of Health Disparities
Eun Ji Kim1,2 , Lyndonna Marrast1,2, and Joseph Conigliaro1,2
1

Division of General Internal Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell 2001 Marcus Avenue Suite S160, Lake
Success, NY, USA; 2Feinstein Institutes of Medical Research Manhasset, NY, USA.

J Gen Intern Med 35(8):2441–2
DOI: 10.1007/s11606-020-05881-4
© Society of General Internal Medicine 2020

disease 19 (COVID-19) is the condition
C oronavirus
caused by severe acute respiratory syndrome coronavirus
2 (SARS-2-CoV-2) infections which is now prevalent in all 50
states with clustering of cases in major cities in New York,
Michigan, California, and New Jersey. COVID-19 that was
initially thought to be the great equalizer—no discrimination
with who can become infected—now reveals patterns of disparities for low-income persons and racial and ethnic minority
populations. This novel coronavirus which results in increased
rates of respiratory failure and death among infected individuals1, 2 is found to disproportionally affect those with comorbidities such as diabetes, heart disease, and asthma. These
conditions are known to disproportionately affect minorities
who are already impacted by health disparities.
Even before COVID-19, health disparities were pervasive
in the USA. We define disparities as differences in healthcare
utilization and health outcomes among distinct social groups.3
Emerging data show that racial/ethnic minorities and those
from the working class have worse health outcomes due to
COVID-19. In Chicago, Blacks comprise 30% of the city’s
population but 70% of COVID-19 deaths. Based on our
personal experience and data from our health system,
COVID-19 is uncovering disparities embedded within our
society. In this paper, we identify areas in which COVID-19
is exacerbating existing disparities and offer potential solutions to address these disparities.
Structural barriers contributed to disparities in COVID-19
testing and diagnosis in the early weeks of the pandemic. One
of the major issues with diagnosing COVID-19 is limited
testing availability. Initially, testing was centralized and there
were few testing sites. To control the number of patients
presenting for tests, residents in New York were required to
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obtain a doctor’s prescription. Previous studies have shown
that racial/ethnic minorities are less likely to have access to a
primary care provider.4 Thus, this requirement may have
served as structural barrier in obtaining COVID-19 testing.
Then, the state implemented “drive-thru” testing to increase
the number of patients receiving tests but this required access
to a vehicle. Though the intention was to control the number of
patients getting tested through prescriptions and “drive-thru”
testing, patients without a doctor or without access to a vehicle
were less likely to be tested. Controlling access to tests in this
way likely disadvantaged racial and ethnic minorities and
those who rely on public transportation. Furthermore, if a
patient has a high clinical suspicion for COVID-19 infection
but lacks a primary care provider or vehicle, their only recourse is to seek testing in an emergency room. Given the cost
of emergency room copays, some patients have to decide
whether to pay to get evaluated for testing or monitor their
symptoms at home. Additionally, COVID-19 results are available 7 to 10 days after and during this time, patients again
encounter a dilemma whether to quarantine themselves at
home or go to work. Therefore, having an established policy
for free and easily accessible COVID-19 testing would reduce
the impact of the structural barriers to testing and, in turn,
minimize disparities.
We are witnessing unintended consequences of the
COVID-19 outbreak; patients with non-COVID-19 medical
conditions avoid healthcare to reduce the risk of COVID-19
exposure. As hospitals are filled with patients who test positive
for COVID-19, COVID-19-negative patients with existing
medical conditions are more susceptible to complications of
those conditions. Cardiologists are noticing a reduction in the
number of patients with heart attacks and those who are
presenting with heart attacks are having worse outcomes.
Surgeons also observe patients that require surgical interventions are presenting with gangrene or with increased risk of
surgical complications. Patients from racial and ethnic minorities have an increased prevalence of common medical conditions compared to non-Hispanic Whites, and a high percentage
of them have undiagnosed common medical conditions.4 To
reduce disparities arising from the management of both
COVID-19 and non-COVID disease outcomes, it is critical
to develop testing to rapidly assess COVID-19 status, isolate
COVID-19 patients from non-COVID patients, and efficiently
manage non-COVID-19 diseases.
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Public health recommendations to contain COVID-19 can
worsen disparities due to a lack of resources and underlying
institutional racism. To reduce the spread of COVID-19, states
have implemented various procedures, including social distancing, wearing masks in public areas, working from home,
and closing schools. These recommendations seem sensible
for containing the disease but may be difficult to implement
depending on one’s social situation. Access to masks has been
difficult given the nationwide shortage of masks. Also, wearing a mask has been associated with having the diseases and,
in some instances, society may perceive criminality (when
none exists). When the government communicates ambiguous
messages about wearing masks to reduce COVID-19 infection, it is difficult for the public, especially racial and ethnic
minorities and the working class, to interpret and adopt the
recommendation. Therefore, it is important to have clear recommendations to ensure general public safety.
Social distancing has contributed to decreased expected
mortality, a positive outcome, but negative impacts will be
the hardest among the working class. In New York, bus drivers
limit the number of passengers riding each bus to respect
social distancing rules. During a phone conversation, a patient
stated that this practice would effectively double his travel
time to the clinic for a doctor’s visit. He usually rides two
buses, but with limits to the maximum number of people
allowed, he more often needs to wait for the next bus. Considering that New York City public transportation is now
running on a weekend schedule, those who rely on public
transportation experience significantly longer travel times
and an increased risk of exposure during the pandemic. This
becomes more problematic if someone is an asymptomatic
carrier of the virus.
Lastly, we are anticipating significant disparities arising
from the lack of health insurance due to one of the highest
unemployment rates in history. In the coming months, this will
have a significant impact on healthcare utilization and health
outcomes. The longer the COVID-19 outbreak persists, the
more employees will be at a risk of becoming furloughed. In
the beginning of the outbreak, a television news anchor suggested that people should receive their health checkups now
while they still have their health insurance as the majority of
people in the USA obtain their health insurance through their
employer. Given the increase in unemployment, it is unclear
what will happen in situations when these uninsured patients
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need medical care. Also, those without health insurance will
no longer receive routine checkups, cancer screening, and
disease management visits. This likely will result in a widening of the disparity gap in the long term, especially among
vulnerable populations.
Though present before the pandemic, health disparities may
increase after our society begins to recover from COVID-19.
Until COVID-19 becomes eradicated or a vaccine is developed, society must combat this disease as one to minimize
mortality, complications, and social consequences (i.e., unemployment) arising from this disease. It is imperative that rapid
COVID-19 screening be freely available to the general public
and those who have an increased risk of exposure. Only then
can we elevate the care for all medical conditions and mitigate
the health disparities arising from COVID-19. Though
COVID-19 is not the great equalizer based on disparities in
outcomes, our response can result in more equitable access to
care for all segments of the population.
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